# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-26-333824
Filing Date
2026-08-05
Accepted
2026-08-05 07:06:25
Documents
61
Period of Report
2026-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | nams-20260630.htm iXBRL | 10-Q | 2021584
2 | EX-10.2 | nams-ex10_2.htm | EX-10.2 | 98160
3 | EX-31.1 | nams-ex31_1.htm | EX-31.1 | 17540
4 | EX-31.2 | nams-ex31_2.htm | EX-31.2 | 17497
5 | EX-32.1 | nams-ex32_1.htm | EX-32.1 | 9855
6 | EX-32.2 | nams-ex32_2.htm | EX-32.2 | 9829
| Complete submission text file | 0001193125-26-333824.txt |  | 7749691

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | nams-20260630.xsd | EX-101.SCH | 767568
65 | EXTRACTED XBRL INSTANCE DOCUMENT | nams-20260630_htm.xml | XML | 1574650

Mailing Address GOOIMEER 2-35 NARRDEN P7 1411 DC
Business Address GOOIMEER 2-35 NARRDEN P7 1411 DC 35 206 2971
NewAmsterdam Pharma Co N.V. (Filer) CIK: 0001936258 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41562 | Film No.: 261241304
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)